Prolonged Exposure to Antimicrobials Induces Changes in Susceptibility to Antibiotics, Biofilm Formation and Pathogenicity in Staphylococcus aureus
Journal of Pharmaceutical Research International,
Introduction: Frequent exposure to certain biocidal agents such as hypochlorous acid (HOCl), triclosan and benzalkonium chloride (BAC) has been reported to induce significant changes in Staphylococcus aureus. However, very few studies of this type have been conducted with conventional antimicrobials.
Aim: The current investigation aimed to explore the phenotypic changes (susceptibility to antibiotics, biofilm formation and relative pathogenicity) that occur in S. aureus after recurrent exposure to antimicrobials.
Methods: We compared the effects of long-term exposure to ampicillin, cefazoline, kanamycin and silver nanoparticles (AgNPs) on their susceptibility to antibiotics, biofilm formation, growth rate and pathogenicity in Staphylococcus aureus ATCC 6538. The minimum inhibitory concentrations (MIC) were determined using the microplate mircodilution method and the bacteria were exposed to increasing concentrations of each antimicrobial (MIC/2 to MIC) prepared in the BHIB for 8 days. The sensitivity of bacteria to antibiotics was assessed using the Kirby-Bauer disc diffusion method, the biofilm formation with crystal violet bacterial attachment assay and relative pathogenicity was assessed through a Galleria mellonella waxworm model.
Results: The data in this investigation indicate that long-term exposure to antimicrobials may induce several changes in S. aureus. The exposure to ampicillin induced resistance to ceftazidime, tetracycline and ceftriaxone while the susceptibility to ceftazidime decreased in bacteria exposed to cefazolin and Kanamycin. Meanwhile, exposure to AgNPs induced some changes in susceptibility to trimethoprim and ceftazidime without causing resistance. Similarly, the strains exposed to ampicillin and kanamycin grew more rapidly and produced more biofilms than the control strains whereas the strains exposed to the AgNPs produced less biofilms. On G. melonella model, cefazolin seems to have attenuated the pathogenicity while the 3 other strains were more pathogenic than the controls.
Conclusion: Long term exposure of S. aureus to antibiotics and AgNPs induces several changes in susceptibility to other antibiotics, growth rate, biofilm formation and pathogenicity; and these changes should be taken into account when choosing antibiotics for treatment of diseases caused by S. aureus.
- Antibiotic resistance
- staphylococcus aureus
- silver nanoparticles
How to Cite
World Health Organization. New report calls for urgent action to avert antimicrobial resistance crisis. World Health Organization, Geneva; 2019.
Retrieved on 28-01-2021.
Manga MJA, Podoprigora IV, Davares AKL, Razan M, Das MS, Senyagin AN. Antibacterial activity of grapefruit peel extracts and green-synthesized silver nanoparticles, Veterinary World. 2021;14(5):1330-1341.
Guo Y, Song G, Sun M, Wang J, Wang Y. Prevalence and therapies of antibiotic-resistance in Staphylococcus aureus. Front. Cell. Infect. Microbiol, 2020;10:107.
Yang H, Xu S, Huang K, Xu X, Hu F, He C, Liu Q. Anti-staphylococcus antibiotics interfere with the transcription of leucocidin ED gene in Staphylococcus aureus strain Newman. Front. Microbiol. 2020;11:265.
Oogai Y, Matsuo M, Hashimoto M, Kato F, Sugai M, Komatsuzawa H. Expression of virulence factors by Staphylococcus aureus grown in serum. Appl. Environ. Microbiol. 2011;77(22):8097-8105.
Latimer J, Forbes S, McBain AJ. Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan. Antimicrob Agents Chemother. 2012;56(6):3092-3100.
Wright GD. Mechanisms of resistance to antibiotics. Curr Opin Chem Biol. 2003;7(5):563-569.
Mc Guinness WA, Malachowa N, DeLeo FR. Focus: Infectious diseases: Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med. 2017;90(2):269–281.
Pokludová L, Prátová H. Wider context of antimicrobial resistance, including molecular biology perspective and implications for clinical practice. In Antimicrobials in Livestock 1: Regulation, Science, Practice. Springer, Cham. 2020;233-279.
Dopcea GN, Dopcea I, Nanu AE, Diguţă CF, Matei F. Resistance and cross-resistance in Staphylococcus spp. strains following prolonged exposure to different antiseptics. J. Glob. Antimicrob. Resist. 2020;21:399-404.
Lan S, Li Z, Su A, Peng Y, Liao Y, Liu X, et al. Study on the mechanisms of the cross-resistance to TET, PIP, and GEN in Staphylococcus aureus mediated by the Rhizoma Coptidis extracts. J. Antibiot. 2021;4:330–336.
Baseri N, Najar-Peerayeh S, Bakhshi B. The effect of subinhibitory concentration of chlorhexidine on the evolution of vancomycin-intermediate Staphylococcus aureus and the induction of mutations in walKR and vraTSR systems. Infection, Genetics and Evolution. 2021;87:104628.
Puangseree J, Jeamsripong S, Prathan R, Pungpian C, Chuanchuen R. Resistance to widely-used disinfectants and heavy metals and cross resistance to antibiotics in Escherichia coli isolated from pigs, pork and pig carcass. Food Control. 2021;124:107892.
Stevens DL, Ma Y, Salmi DB, McIndoo E, Wallace RJ, Bryant AE. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J. Infect. Dis. 2007;195(2):202-211.
Diep BA, Afasizheva A, Le HN, Kajikawa O, Matute-Bello G, Tkaczyk C, et al. Effects of linezolid on suppressing in vivo production of staphylococcal toxins and improving survival outcomes in a rabbit model of methicillin-resistant Staphylococcus aureus necrotizing pneumonia. J. Infect. Dis. 2013;208(1):75-82.
Yamaki J, Synold T, Wong-Beringer A. Tigecycline induction of phenol-soluble modulins by invasive methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother. 2013;57(9):4562-4565.
Turner CE, Sriskandan S. Panton–Valentine leucocidin expression by Staphylococcus aureus exposed to common antibiotics. Journal of Infection. 2015;71(3):338-346.
Hodille E, Rose W, Diep BA, Goutelle S, Lina G, Dumitrescu O. The role of antibiotics in modulating virulence in Staphylococcus aureus. Clin Microbiol Rev. 2017;30(4):887-917.
Liu Q, Zheng Z, Kim W, Burgwyn Fuchs B, Mylonakis E. Influence of subinhibitory concentrations of NH125 on biofilm formation & virulence factors of Staphylococcus aureus. Future Med. Chem. 2018;10(11):1319-1331.
Mbarga MJA, Podoprigora IV, Volina EG, Ermolaev AV, Smolyakova LA. Evaluation of Changes Induced in the Probiotic Escherichia coli M17 Following Recurrent Exposure to Antimicrobials. Journal of Pharmaceutical Research International. 2021;3(29B):158-167.
Arsene MMJ, Andreevna SL, Viktorovna PI. Evaluation of apparent microflora and study of antibiotic resistance of coliforms isolated from the shells of poultry eggs in Moscow-Russia. Journal of Advances in Microbiology. 2020;20(4):70-77.
NCCLs: Clinical and Laboratory Standards Institute. Control methods. Biological and micro-biological factors: Determination of the sensitivity of microorganisms to antibacterial drugs. Federal Center for Sanitary and Epidemiological Surveillance of Ministry of Health of Russia; 2019.
Abid N, Maalej S, Rouis S. Morphological and physiological changes of Staphylococcus aureus exposed to hypochlorous acid. Lett Appl Microbiol. 2004;38(3):245-250.
Henly EL, Dowling JAR, Maingay JB, Lacey MM, Smith TJ, Forbes S. Biocide exposure induces changes in susceptibility, pathogenicity, and biofilm formation in uropathogenic Escherichia coli. Antimicrob Agents Chemother. 2019; 63(3):e01892-18.
Pantosti A, Sanchini A, Monaco M. Mechanisms of antibiotic resistance in Staphylococcus aureus. Future Medicine; 2007.
Thitiananpakorn K, Aiba Y, Tan XE, Watanabe S, Kiga K, Sato’o Y, et al. Association of mprF mutations with cross-resistance to daptomycin and vancomycin in methicillin-resistant Staphylococcus aureus (MRSA). Scientific Reports. 2020;10(1):1-15.
Allen MJ, White GF, Morby AP. The response of Escherichia coli to exposure to the biocide polyhexamethylene biguanide. Microbiology. 2006;152:989–1000.
Bui LM, Conlon BP, Kidd SP. Antibiotic tolerance and the alternative lifestyles of Staphylococcus aureus. Essays in Biochemistry. 2017;61(1):71-79.
Taylor TA, Unakal CG. Staphylococcus aureus, in Stat Pearls, Treasure Island, FL; 2019.
Liu GY, Essex A, Buchanan JT, Datta V, Hoffman HM, Bastian JF, et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 2005;202(2):209- 215.
Zhang J, Suo Y, Zhang D, Jin F, Zhao H, Shi C. Genetic and virulent difference between pigmented and non-pigmented Staphylococcus aureus. Front. Microbial. 2018;9:598.
Del Pozo JL. Biofilm-related disease. Expert Rev Anti Infect The. 2018;16(1):51-65.
Balasubramanian D, Ohneck EA, Chapman J, Weiss A, Kim MK, Reyes-Robles T, et al. Staphylococcus aureus coordinates leukocidin expression and pathogenesis by sensing metabolic fluxes via RpiRc. MBio. 2016;7(3):e00818-16.
Alonzo F, Torres VJ. The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev. 2014;78(2):199-230.
He C, Xu S, Zhao H, Hu F, Xu X, Jin S, Liu Q. Leukotoxin and pyrogenic toxin Superantigen gene backgrounds in bloodstream and wound Staphylococcus aureus isolates from eastern region of China. BMC Infect Dis. 2018;18(1):1-10.
Reyes-Robles T, Alonzo IIIF, Kozhaya L, Lacy DB, Unutmaz D, Torres VJ. Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host & Microbe. 2013;14(4):453-459.
Spaan AN, Reyes-Robles T, Badiou C, Cochet S, Boguslawski KM, Yoong P, Torres VJ. Staphylococcus aureus targets the Duffy antigen receptor for chemokines (DARC) to lyse erythrocytes. Cell host & Microbe. 2015;18(3):363-370.
Abstract View: 0 times
PDF Download: 0 times